Biotech Fluidics report how installation of two DEGASi® Plus semi-prep 6-channel degassing systems on a production line, has enabled a diagnostic kit manufacturer to almost eliminate inaccurate reagent dispensing issues.
The long-term PERFECT observational study follows patients from successful Phase I/IIb of ProtheraCytes for the repair and regeneration of damaged cardiac tissues after severe heart attack.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.